Washington. In the US, there have been many positive results of anti-viral drug Remadecivir for treatment with coronavirus. President Donald Trump and Infexious Disease Scientist Anthony Fauci have reported the results of early trials of Remedisvir as better. Fauci has hoped that this drug can curb the rate of rising deaths. The US Department of Food Drug and Administration (FDA) may soon announce its use.
Recovery rate of patients increased with Remedisivir
Earlier, Trump described hydroxychloroquine as an effective drug in Corona. However, it was then rejected by Doctor Fauci. Now after expressing the hope of the Fauci, this medicine is believed to be effective. Fauci said, “Use of this drug will help in increasing the recovery rate of patients. However, the National Institute of Allergy and Infectious Disease is conducting a more in-depth review of drug test results. The test indicated that remadecivir may reduce the recovery time by one third. That means a patient recovering in 15 days will be cured in five days. Currently, the study is expected to improve by 31 percent. Nevertheless it is very important. Because it has been proven that this drug can stop the virus. "Trump also called it a good sign. Said, "This is definitely a big positive event."
Gilead Sciences made Remedesvir for the treatment of Ebola
American biopharmaceutical company Gilead Sciences made Remedisvir during the Ebola epidemic. However, disappointment was at stake during its clinical trial in Africa. The special thing is that Remadecivir was never approved for treatment of any disease. According to Gilead, Remedisvir is not yet licensed or approved in the US or anywhere in the world.
Remedesivir production being increased
Gilead Sciences spokesman Ryan McKeel said the company could not speculate on what action the government would take. However, we are discussing with him the use of Remadecivir as a treatment for Covid-19 and positive results in the trial. Increasing the production of Remadecivir. If needed immediately, we can provide it.
Test done on 1000 people
Gilead Sciences has conducted a three-phase trial of this drug at 1000 volantiers. Fauci said that trials with the US began in Britain, Germany, Denmark, Spain and Greece. One thing is common that the use of this medicine is helping the patient recover. This drug inhibits a special type of enzyme in the body, by using which the coronavirus spreads in the body.
Thwarted in china
No positive effect was seen on Covid-19 patients in a study in China regarding this drug. The study was also published in the journal Lancet. However, it was said in the study that Remedisvir may prove useful to others elsewhere, but it did not show much effect in China. The study in China tested it on very few people. Dr. Bin Chao of the Capital Medical University of Beijing said, "Unfortunately, no benefit of Remedesiver was revealed in our trial."
What is placebo
Researchers say that 8% of the people who were given Remedisivir could not be saved. At the same time, 11% of the patients who survived were given placebo. Plesibo is a treatment in which the patient will recover on his own with strong willpower. For example, when patients complain about a disease and doctors do not find anything in the investigation, they give any sweet pill. In such a situation, the patient is confident that the doctor has given him the right medicine and his will power to recover becomes strong. Due to this, he gets well. This method of treatment is called placebo. It is not known whether Remedisvir has an effect on Covid-19. However, those who participated in the trial felt that he would recover from this drug, so his recovery speed increased. All this happened due to the will power of his mind.
Today is the 40th and important day of the farmers' agitation against agricultural laws. The 8th
The MPs, suspended from the House for a week on allegations of creating ruckus in Parliament, are
Many players of the England cricket team have left IPL 2024 midway and returned home. The England
SSC Constable Recruitment: Last date to apply for more than 1400 posts is today, hurry up
SSC Recruitment 2022: If you are working hard day and night in preparation for a government job a
Shubman Gill: 'Wouldn't be surprised if Gill becomes T20 captain', says former England spinner
Former England spinner Monty Panesar has praised the decision to hand Shubman Gill the captaincy
The court is to hear the case on Friday on the claim of a temple in Rajasthan's Ajmer Dargah. Vis
The temperature in the world's coldest city has reached -50 degrees Celsius. The situation is tha
The joint team of the National Investigation Agency (NIA), Enforcement Directorate (ED), and stat
Yashasvi Jaiswal on Sachin Tendulkar: Team India won by 106 runs in the second test match of Indi
America has expressed concern over Canadian diplomats leaving India. The US State Department said
